Sanofi SA (SNY)
46.16
+0.34
(+0.73%)
USD |
NASDAQ |
Apr 17, 15:41
Sanofi Total Liabilities (Quarterly): 57.60B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 57.60B |
June 30, 2023 | 56.95B |
December 31, 2022 | 55.30B |
June 30, 2022 | 52.77B |
December 31, 2021 | 57.98B |
June 30, 2021 | 58.26B |
June 30, 2020 | 58.86B |
December 31, 2019 | 59.82B |
June 30, 2019 | 61.43B |
December 31, 2018 | 59.91B |
June 30, 2018 | 65.23B |
December 31, 2017 | 49.88B |
December 31, 2016 | 49.64B |
December 31, 2015 | 48.23B |
June 30, 2015 | 46.15B |
December 31, 2014 | 50.01B |
June 30, 2014 | 53.14B |
December 31, 2013 | 53.88B |
June 30, 2013 | 53.16B |
December 31, 2012 | 56.75B |
June 30, 2012 | 56.47B |
Date | Value |
---|---|
December 31, 2011 | 57.39B |
June 30, 2011 | 68.03B |
December 31, 2010 | 42.53B |
June 30, 2010 | 41.17B |
December 31, 2009 | 45.29B |
June 30, 2009 | 44.88B |
December 31, 2008 | 37.61B |
June 30, 2008 | 41.04B |
December 31, 2007 | 39.69B |
June 30, 2007 | 39.19B |
December 31, 2006 | 42.14B |
June 30, 2006 | 46.59B |
December 31, 2005 | 48.06B |
June 30, 2005 | 53.90B |
December 31, 2004 | 59.48B |
June 30, 2004 | 4.512B |
December 31, 2003 | 4.281B |
June 30, 2003 | 3.711B |
December 31, 2002 | 3.577B |
June 30, 2002 | 3.487B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
52.77B
Minimum
Jun 2022
61.43B
Maximum
Jun 2019
57.66B
Average
57.98B
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
AstraZeneca PLC | 61.95B |
GSK PLC | 58.87B |
Novo Nordisk A/S | 30.87B |
Regeneron Pharmaceuticals Inc | 7.107B |
Inhibrx Inc | 264.39M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 139.79B |
Shareholders Equity (Quarterly) | 81.84B |
Debt to Equity Ratio | 0.2214 |
Current Ratio | 1.267 |
Net Debt Paydown Yield | -2.91% |